Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions

por Miramin-Mohammadi, Akram, Javadi, Amir, Eskandari, Seyed Ebrahim, Mortazavi, Hossein, Rostami, Mahmoud Nateghi, Khamesipour, Ali
Publicado 2020

Treatment of Cutaneous Lesion of 20 Years’ Duration Caused by Leishmanization

por Khamesipour, Ali, Abbasi, Azam, Firooz, Alireza, Mohammadi, Akram Mir Amin, Eskandari, Seyed Ebrahim, Jaafari, Mahmoud R.
Publicado 2012

Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial

por ESKANDARI, Seyed Ebrahim, FIROOZ, Alireza, NASSIRI-KASHANI, Mansour, JAAFARI, Mahmoud Reza, JAVADI, Amir, MIRAMIN MOHAMMADI, Akram, KHAMESIPOUR, Ali
Publicado 2019

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis

por Eskandari, Seyed Ebrahim, Firooz, Alireza, Nassiri-Kashani, Mansour, Jaafari, Mahmoud Reza, Javadi, Amir, Miramin-Mohammadi, Akram, Valian-Keshavarz, Hossein, Khamesipour, Ali
Publicado 2018

Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized c...

por Javadi, Amir, Khamesipour, Ali, Ghoorchi, Mohammad, Bahrami, Mahdieh, Khatami, Alireza, Sharifi, Iraj, Eskandari, Seyed Ebrahim, Fekri, Alireza, Aflatoonian, Mohamad Reza, Firooz, Alireza
Publicado 2022

Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishm...

por Eskandari, Seyed Ebrahim, Khamesipour, Ali, Jaafari, Mahmoud Reza, Javadi, Amir, Mohammadi, Akram Miramin, Valian, Hossein Keshavarz, Nassiri-Kashani, Mansour, Goyonlo, Vahid Mashayekhi, Firooz, Alireza
Publicado 2021